7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis

NCT00115089 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG: R926112
DRUG: Beclomethasone dipropionate

Sponsor

Rigel Pharmaceuticals